Table 1 Patient characteristics
From: Low rate of severe-end-stage kidney disease after SABR for localised primary kidney cancer
Patient characteristic | All patients (n = 78) |
|---|---|
Age at SABR (years) | |
 Median (IQR) | 77.8 (70.4–82.6) |
Gender | |
 Male | 57 (73%) |
 Female | 21 (27%) |
ECOG PS | |
 0 | 36 (46%) |
 1 | 25 (32%) |
 2 | 17 (22%) |
Pathological confirmation | 67 (85.9%) |
Tumor size (cm) | |
 Mean (SD) | 4.8 (1.3) |
 < 4 | 25 (32%) |
 ≥ 4 | 53 (68%) |
Tumor side | |
 Left | 36 (46%) |
 Right | 42 (54%) |
Solitary versus dual kidneys | |
 Dual kidneys | 72 (92.4%) |
 Single kidney | 6 (7.6%) |
Ipsilateral (Target) kidney percentage function median (IQR) | 49.5% (46–52%) |
Baseline CKD stage | |
 1–2 | 35 (44.9%) |
 3a | 27 (34.6%) |
 3b | 16 (20.5%) |
T stage | |
 1 | 70 (90%) |
 2 | 5 (6%) |
 3 | 3 (4%) |
Hypertension | |
 Yes | 62 (79%) |
 No | 16 (21%) |
Diabetes mellites | |
 Yes | 38 (49%) |
 No | 40 (51%) |
SABR fractions | |
 Single | 31 (40%) |
 Multiple | 47 (60%) |